Global Gene Therapy for Inherited Genetic Disorders Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Description

In the medicine field gene therapy (also called human gene transfer) is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease.A genetic disorder is a genetic problem caused by one or more abnormalities formed in the genome.

According to our (Global Info Research) latest study, the global Gene Therapy for Inherited Genetic Disorders market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Gene therapy has the potential to cure inherited diseases that cannot be cured using conventional drugs. It is being increasingly adopted in clinical trials because of its high efficacy and safety towards the treatment of inherited genetic disorders.

This report is a detailed and comprehensive analysis for global Gene Therapy for Inherited Genetic Disorders market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Gene Therapy for Inherited Genetic Disorders market size and forecasts, in consumption value ($ Million), 2018-2029
Global Gene Therapy for Inherited Genetic Disorders market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Gene Therapy for Inherited Genetic Disorders market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Gene Therapy for Inherited Genetic Disorders market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gene Therapy for Inherited Genetic Disorders
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gene Therapy for Inherited Genetic Disorders market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BioMarin Pharmaceutical Inc., bluebird bio Inc., Novartis AG, Orchard Therapeutics Plc and Spark Therapeutics Inc.. etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Gene Therapy for Inherited Genetic Disorders market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Eye Disorders
    Hematological Disorders
    Central Nervous System Disorders
    Muscular Disorders
    Others

Market segment by Application
    Hospital
    Clinic
    Research Institute
    Others

Market segment by players, this report covers
    BioMarin Pharmaceutical Inc.
    bluebird bio Inc.
    Novartis AG
    Orchard Therapeutics Plc
    Spark Therapeutics Inc.

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gene Therapy for Inherited Genetic Disorders product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gene Therapy for Inherited Genetic Disorders, with revenue, gross margin and global market share of Gene Therapy for Inherited Genetic Disorders from 2018 to 2023.
Chapter 3, the Gene Therapy for Inherited Genetic Disorders competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Gene Therapy for Inherited Genetic Disorders market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Gene Therapy for Inherited Genetic Disorders.
Chapter 13, to describe Gene Therapy for Inherited Genetic Disorders research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Gene Therapy for Inherited Genetic Disorders
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Gene Therapy for Inherited Genetic Disorders by Type
        1.3.1 Overview: Global Gene Therapy for Inherited Genetic Disorders Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Type in 2022
        1.3.3 Eye Disorders
        1.3.4 Hematological Disorders
        1.3.5 Central Nervous System Disorders
        1.3.6 Muscular Disorders
        1.3.7 Others
    1.4 Global Gene Therapy for Inherited Genetic Disorders Market by Application
        1.4.1 Overview: Global Gene Therapy for Inherited Genetic Disorders Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital
        1.4.3 Clinic
        1.4.4 Research Institute
        1.4.5 Others
    1.5 Global Gene Therapy for Inherited Genetic Disorders Market Size & Forecast
    1.6 Global Gene Therapy for Inherited Genetic Disorders Market Size and Forecast by Region
        1.6.1 Global Gene Therapy for Inherited Genetic Disorders Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Gene Therapy for Inherited Genetic Disorders Market Size by Region, (2018-2029)
        1.6.3 North America Gene Therapy for Inherited Genetic Disorders Market Size and Prospect (2018-2029)
        1.6.4 Europe Gene Therapy for Inherited Genetic Disorders Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size and Prospect (2018-2029)
        1.6.6 South America Gene Therapy for Inherited Genetic Disorders Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Gene Therapy for Inherited Genetic Disorders Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 BioMarin Pharmaceutical Inc.
        2.1.1 BioMarin Pharmaceutical Inc. Details
        2.1.2 BioMarin Pharmaceutical Inc. Major Business
        2.1.3 BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Product and Solutions
        2.1.4 BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 BioMarin Pharmaceutical Inc. Recent Developments and Future Plans
    2.2 bluebird bio Inc.
        2.2.1 bluebird bio Inc. Details
        2.2.2 bluebird bio Inc. Major Business
        2.2.3 bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Product and Solutions
        2.2.4 bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 bluebird bio Inc. Recent Developments and Future Plans
    2.3 Novartis AG
        2.3.1 Novartis AG Details
        2.3.2 Novartis AG Major Business
        2.3.3 Novartis AG Gene Therapy for Inherited Genetic Disorders Product and Solutions
        2.3.4 Novartis AG Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Novartis AG Recent Developments and Future Plans
    2.4 Orchard Therapeutics Plc
        2.4.1 Orchard Therapeutics Plc Details
        2.4.2 Orchard Therapeutics Plc Major Business
        2.4.3 Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Product and Solutions
        2.4.4 Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Orchard Therapeutics Plc Recent Developments and Future Plans
    2.5 Spark Therapeutics Inc.
        2.5.1 Spark Therapeutics Inc. Details
        2.5.2 Spark Therapeutics Inc. Major Business
        2.5.3 Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Product and Solutions
        2.5.4 Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Spark Therapeutics Inc. Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Gene Therapy for Inherited Genetic Disorders Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Gene Therapy for Inherited Genetic Disorders by Company Revenue
        3.2.2 Top 3 Gene Therapy for Inherited Genetic Disorders Players Market Share in 2022
        3.2.3 Top 6 Gene Therapy for Inherited Genetic Disorders Players Market Share in 2022
    3.3 Gene Therapy for Inherited Genetic Disorders Market: Overall Company Footprint Analysis
        3.3.1 Gene Therapy for Inherited Genetic Disorders Market: Region Footprint
        3.3.2 Gene Therapy for Inherited Genetic Disorders Market: Company Product Type Footprint
        3.3.3 Gene Therapy for Inherited Genetic Disorders Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Gene Therapy for Inherited Genetic Disorders Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Gene Therapy for Inherited Genetic Disorders Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Application (2018-2023)
    5.2 Global Gene Therapy for Inherited Genetic Disorders Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2018-2029)
    6.2 North America Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2018-2029)
    6.3 North America Gene Therapy for Inherited Genetic Disorders Market Size by Country
        6.3.1 North America Gene Therapy for Inherited Genetic Disorders Consumption Value by Country (2018-2029)
        6.3.2 United States Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2018-2029)
        6.3.3 Canada Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2018-2029)
        6.3.4 Mexico Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2018-2029)
    7.2 Europe Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2018-2029)
    7.3 Europe Gene Therapy for Inherited Genetic Disorders Market Size by Country
        7.3.1 Europe Gene Therapy for Inherited Genetic Disorders Consumption Value by Country (2018-2029)
        7.3.2 Germany Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2018-2029)
        7.3.3 France Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2018-2029)
        7.3.5 Russia Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2018-2029)
        7.3.6 Italy Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Market Size by Region
        8.3.1 Asia-Pacific Gene Therapy for Inherited Genetic Disorders Consumption Value by Region (2018-2029)
        8.3.2 China Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2018-2029)
        8.3.3 Japan Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2018-2029)
        8.3.4 South Korea Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2018-2029)
        8.3.5 India Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2018-2029)
        8.3.7 Australia Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2018-2029)
    9.2 South America Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2018-2029)
    9.3 South America Gene Therapy for Inherited Genetic Disorders Market Size by Country
        9.3.1 South America Gene Therapy for Inherited Genetic Disorders Consumption Value by Country (2018-2029)
        9.3.2 Brazil Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2018-2029)
        9.3.3 Argentina Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Market Size by Country
        10.3.1 Middle East & Africa Gene Therapy for Inherited Genetic Disorders Consumption Value by Country (2018-2029)
        10.3.2 Turkey Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2018-2029)
        10.3.4 UAE Gene Therapy for Inherited Genetic Disorders Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Gene Therapy for Inherited Genetic Disorders Market Drivers
    11.2 Gene Therapy for Inherited Genetic Disorders Market Restraints
    11.3 Gene Therapy for Inherited Genetic Disorders Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Gene Therapy for Inherited Genetic Disorders Industry Chain
    12.2 Gene Therapy for Inherited Genetic Disorders Upstream Analysis
    12.3 Gene Therapy for Inherited Genetic Disorders Midstream Analysis
    12.4 Gene Therapy for Inherited Genetic Disorders Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Gene Therapy for Inherited Genetic Disorders Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Gene Therapy for Inherited Genetic Disorders Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Gene Therapy for Inherited Genetic Disorders Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Gene Therapy for Inherited Genetic Disorders Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. BioMarin Pharmaceutical Inc. Company Information, Head Office, and Major Competitors
    Table 6. BioMarin Pharmaceutical Inc. Major Business
    Table 7. BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Product and Solutions
    Table 8. BioMarin Pharmaceutical Inc. Gene Therapy for Inherited Genetic Disorders Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. BioMarin Pharmaceutical Inc. Recent Developments and Future Plans
    Table 10. bluebird bio Inc. Company Information, Head Office, and Major Competitors
    Table 11. bluebird bio Inc. Major Business
    Table 12. bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Product and Solutions
    Table 13. bluebird bio Inc. Gene Therapy for Inherited Genetic Disorders Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. bluebird bio Inc. Recent Developments and Future Plans
    Table 15. Novartis AG Company Information, Head Office, and Major Competitors
    Table 16. Novartis AG Major Business
    Table 17. Novartis AG Gene Therapy for Inherited Genetic Disorders Product and Solutions
    Table 18. Novartis AG Gene Therapy for Inherited Genetic Disorders Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Novartis AG Recent Developments and Future Plans
    Table 20. Orchard Therapeutics Plc Company Information, Head Office, and Major Competitors
    Table 21. Orchard Therapeutics Plc Major Business
    Table 22. Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Product and Solutions
    Table 23. Orchard Therapeutics Plc Gene Therapy for Inherited Genetic Disorders Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Orchard Therapeutics Plc Recent Developments and Future Plans
    Table 25. Spark Therapeutics Inc. Company Information, Head Office, and Major Competitors
    Table 26. Spark Therapeutics Inc. Major Business
    Table 27. Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Product and Solutions
    Table 28. Spark Therapeutics Inc. Gene Therapy for Inherited Genetic Disorders Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Spark Therapeutics Inc. Recent Developments and Future Plans
    Table 30. Global Gene Therapy for Inherited Genetic Disorders Revenue (USD Million) by Players (2018-2023)
    Table 31. Global Gene Therapy for Inherited Genetic Disorders Revenue Share by Players (2018-2023)
    Table 32. Breakdown of Gene Therapy for Inherited Genetic Disorders by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 33. Market Position of Players in Gene Therapy for Inherited Genetic Disorders, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 34. Head Office of Key Gene Therapy for Inherited Genetic Disorders Players
    Table 35. Gene Therapy for Inherited Genetic Disorders Market: Company Product Type Footprint
    Table 36. Gene Therapy for Inherited Genetic Disorders Market: Company Product Application Footprint
    Table 37. Gene Therapy for Inherited Genetic Disorders New Market Entrants and Barriers to Market Entry
    Table 38. Gene Therapy for Inherited Genetic Disorders Mergers, Acquisition, Agreements, and Collaborations
    Table 39. Global Gene Therapy for Inherited Genetic Disorders Consumption Value (USD Million) by Type (2018-2023)
    Table 40. Global Gene Therapy for Inherited Genetic Disorders Consumption Value Share by Type (2018-2023)
    Table 41. Global Gene Therapy for Inherited Genetic Disorders Consumption Value Forecast by Type (2024-2029)
    Table 42. Global Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2018-2023)
    Table 43. Global Gene Therapy for Inherited Genetic Disorders Consumption Value Forecast by Application (2024-2029)
    Table 44. North America Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2018-2023) & (USD Million)
    Table 45. North America Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2024-2029) & (USD Million)
    Table 46. North America Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2018-2023) & (USD Million)
    Table 47. North America Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2024-2029) & (USD Million)
    Table 48. North America Gene Therapy for Inherited Genetic Disorders Consumption Value by Country (2018-2023) & (USD Million)
    Table 49. North America Gene Therapy for Inherited Genetic Disorders Consumption Value by Country (2024-2029) & (USD Million)
    Table 50. Europe Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2018-2023) & (USD Million)
    Table 51. Europe Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2024-2029) & (USD Million)
    Table 52. Europe Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2018-2023) & (USD Million)
    Table 53. Europe Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2024-2029) & (USD Million)
    Table 54. Europe Gene Therapy for Inherited Genetic Disorders Consumption Value by Country (2018-2023) & (USD Million)
    Table 55. Europe Gene Therapy for Inherited Genetic Disorders Consumption Value by Country (2024-2029) & (USD Million)
    Table 56. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2018-2023) & (USD Million)
    Table 57. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2024-2029) & (USD Million)
    Table 58. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2018-2023) & (USD Million)
    Table 59. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2024-2029) & (USD Million)
    Table 60. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Consumption Value by Region (2018-2023) & (USD Million)
    Table 61. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Consumption Value by Region (2024-2029) & (USD Million)
    Table 62. South America Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2018-2023) & (USD Million)
    Table 63. South America Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2024-2029) & (USD Million)
    Table 64. South America Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2018-2023) & (USD Million)
    Table 65. South America Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2024-2029) & (USD Million)
    Table 66. South America Gene Therapy for Inherited Genetic Disorders Consumption Value by Country (2018-2023) & (USD Million)
    Table 67. South America Gene Therapy for Inherited Genetic Disorders Consumption Value by Country (2024-2029) & (USD Million)
    Table 68. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2018-2023) & (USD Million)
    Table 69. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Consumption Value by Type (2024-2029) & (USD Million)
    Table 70. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2018-2023) & (USD Million)
    Table 71. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Consumption Value by Application (2024-2029) & (USD Million)
    Table 72. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Consumption Value by Country (2018-2023) & (USD Million)
    Table 73. Middle East & Africa Gene Therapy for Inherited Genetic Disorders Consumption Value by Country (2024-2029) & (USD Million)
    Table 74. Gene Therapy for Inherited Genetic Disorders Raw Material
    Table 75. Key Suppliers of Gene Therapy for Inherited Genetic Disorders Raw Materials
List of Figures
    Figure 1. Gene Therapy for Inherited Genetic Disorders Picture
    Figure 2. Global Gene Therapy for Inherited Genetic Disorders Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Type in 2022
    Figure 4. Eye Disorders
    Figure 5. Hematological Disorders
    Figure 6. Central Nervous System Disorders
    Figure 7. Muscular Disorders
    Figure 8. Others
    Figure 9. Global Gene Therapy for Inherited Genetic Disorders Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 10. Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Application in 2022
    Figure 11. Hospital Picture
    Figure 12. Clinic Picture
    Figure 13. Research Institute Picture
    Figure 14. Others Picture
    Figure 15. Global Gene Therapy for Inherited Genetic Disorders Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 16. Global Gene Therapy for Inherited Genetic Disorders Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 17. Global Market Gene Therapy for Inherited Genetic Disorders Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 18. Global Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Region (2018-2029)
    Figure 19. Global Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Region in 2022
    Figure 20. North America Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 21. Europe Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 22. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 23. South America Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 24. Middle East and Africa Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 25. Global Gene Therapy for Inherited Genetic Disorders Revenue Share by Players in 2022
    Figure 26. Gene Therapy for Inherited Genetic Disorders Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 27. Global Top 3 Players Gene Therapy for Inherited Genetic Disorders Market Share in 2022
    Figure 28. Global Top 6 Players Gene Therapy for Inherited Genetic Disorders Market Share in 2022
    Figure 29. Global Gene Therapy for Inherited Genetic Disorders Consumption Value Share by Type (2018-2023)
    Figure 30. Global Gene Therapy for Inherited Genetic Disorders Market Share Forecast by Type (2024-2029)
    Figure 31. Global Gene Therapy for Inherited Genetic Disorders Consumption Value Share by Application (2018-2023)
    Figure 32. Global Gene Therapy for Inherited Genetic Disorders Market Share Forecast by Application (2024-2029)
    Figure 33. North America Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Type (2018-2029)
    Figure 34. North America Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Application (2018-2029)
    Figure 35. North America Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Country (2018-2029)
    Figure 36. United States Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 37. Canada Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 38. Mexico Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 39. Europe Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Type (2018-2029)
    Figure 40. Europe Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Application (2018-2029)
    Figure 41. Europe Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Country (2018-2029)
    Figure 42. Germany Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 43. France Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 44. United Kingdom Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 45. Russia Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 46. Italy Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 47. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Type (2018-2029)
    Figure 48. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Application (2018-2029)
    Figure 49. Asia-Pacific Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Region (2018-2029)
    Figure 50. China Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 51. Japan Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 52. South Korea Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 53. India Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 54. Southeast Asia Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 55. Australia Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 56. South America Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Type (2018-2029)
    Figure 57. South America Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Application (2018-2029)
    Figure 58. South America Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Country (2018-2029)
    Figure 59. Brazil Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 60. Argentina Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 61. Middle East and Africa Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Type (2018-2029)
    Figure 62. Middle East and Africa Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Application (2018-2029)
    Figure 63. Middle East and Africa Gene Therapy for Inherited Genetic Disorders Consumption Value Market Share by Country (2018-2029)
    Figure 64. Turkey Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 65. Saudi Arabia Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 66. UAE Gene Therapy for Inherited Genetic Disorders Consumption Value (2018-2029) & (USD Million)
    Figure 67. Gene Therapy for Inherited Genetic Disorders Market Drivers
    Figure 68. Gene Therapy for Inherited Genetic Disorders Market Restraints
    Figure 69. Gene Therapy for Inherited Genetic Disorders Market Trends
    Figure 70. Porters Five Forces Analysis
    Figure 71. Manufacturing Cost Structure Analysis of Gene Therapy for Inherited Genetic Disorders in 2022
    Figure 72. Manufacturing Process Analysis of Gene Therapy for Inherited Genetic Disorders
    Figure 73. Gene Therapy for Inherited Genetic Disorders Industrial Chain
    Figure 74. Methodology
    Figure 75. Research Process and Data Source

Companies Mentioned

BioMarin Pharmaceutical Inc.
bluebird bio Inc.
Novartis AG
Orchard Therapeutics Plc
Spark Therapeutics Inc.